20160128 EGA Regulatory and Scientific Affairs Conferenc

Joint Declaration on Pharmaceuticals in the Environment

10 April 2018

We, the signatories of this declaration, recognise and understand the […]

Read more

Increasing access to cancer medicines: what role do biosimilar medicines play?

9 April 2018


Generic industry boss: SPC manufacturing waiver won’t harm originators’ innovation

30 March 2018


Statement in response to the EU Council ratifying the Brexit transition deal

23 March 2018

Today’s agreement on a transition period is welcome news for […]

Read more

European health community issues key questions Article 50 negotiations must answer for patients and public health

8 March 2018

The European Health Community has warned that time is running […]

Read more

Supply chain commitment to tackling problem of medicine shortages

2 March 2018


El sistema español podría mejorar su coste-eficiencia con un plan nacional

27 February 2018


IGBA launches a biosimilar medicines information campaign

1 February 2018


IGBA congratulates the Australian government for maintaining their biologics naming convention and for strengthening pharmacovigilance

29 January 2018


2018 – A year of unprecedented challenges and opportunities for pharmaceutical regulatory systems

25 January 2018

This week in London, Medicines for Europe gathers regulators and […]

Read more

Subscribe to our newsletter